Q4FY21 | Sequent Scientific Notes
Sequent 2.0
 |
High Level Notes
India business doubled from 39 cr. to 78 cr. driven by two factors - underlying growth of existing products and commercialisation of Zoetis portfolio
Company has laid out a chart for making ~200 cr. in investments in the next 2 years and renew focus on India, Turkey and Brazil
An advisory board has been put into place to help the company …
